| Michael Kevin O'connor, MD | |
|
183 South Orange Avenue, Suite E1559, Newark, NJ 07107-3000 | |
| (973) 972-2977 | |
| (973) 972-2979 |
| Full Name | Michael Kevin O'connor |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 183 South Orange Avenue, Newark, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033257431 | NPI | - | NPPES |
| 0050199 | Medicaid | NJ |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Kevin O'connor, MD 30 Bergen St, Admc 12 1205, Newark, NJ 07107-3000 Ph: () - | Michael Kevin O'connor, MD 183 South Orange Avenue, Suite E1559, Newark, NJ 07107-3000 Ph: (973) 972-2977 |
News Archive
Dakota Laboratories LLC and its president, Charles L. Voellinger, Sr., are prohibited from manufacturing and distributing drugs until they correct their ongoing violations of the drug manufacturing laws.
ISTA Pharmaceuticals, Inc. today highlighted results from the Company's REMURA (bromfenac ophthalmic solution for dry eye) Phase 2 clinical study.
Researchers at Mayo Clinic Cancer Center have developed new guidelines to treat recently diagnosed multiple myeloma patients who are not participating in clinical trials. The guidelines give physicians practical, easy to follow recommendations for providing initial therapy, stem cell transplant and maintenance therapy.
The launch of the International Genomics of Alzheimer's Project (IGAP) - a collaboration formed to discover and map the genes that contribute to Alzheimer's disease - was announced today by a multi-national group of researchers including Drs. Lindsay Farrer and Sudha Seshadri at Boston University School of Medicine (BUSM). The collaborative effort, spanning universities from both sides of the Atlantic, will combine the knowledge, staff and resources of four consortia that work on Alzheimer's disease genetics.
A team of Israeli and American researchers have found that silicon nanomaterials used for the localized delivery of chemotherapy drugs behave differently in cancerous tumors than they do in healthy tissues. The findings could help scientists better design such materials to facilitate the controlled and targeted release of the chemotherapy drugs to tumors.
› Verified 7 days ago
Petros Levounis, MD, MA Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 183 S Orange Ave, Room F-1436, Newark, NJ 07103 Phone: 973-972-7117 Fax: 973-972-7804 | |
Dr. Candace Tom Saldarini, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3 Penn Plz E, Floor 3, Newark, NJ 07105 Phone: 973-364-2002 | |
Davina Etwaru, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 973-926-7444 | |
Dr. Rashi Aggarwal, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 183 South Orange Avenue, Newark, NJ 07103 Phone: 973-972-1612 | |
Dr. Chiang L Lin, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1160 Raymond Blvd, Newark, NJ 07102 Phone: 973-596-3857 | |
Dr. Rafik Monir Istafanous, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 183 South Orange Ave, E Level Room E 1546, Newark, NJ 07101 Phone: 973-972-5054 Fax: 873-972-3399 | |
Muhammad Zeshan, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 183 S Orange Ave Ste E1546, Newark, NJ 07103 Phone: 973-972-2977 |